Press release
Cancer Therapeutics (Biotherapeutics) Market to Reach USD 262.4 Billion by 2034
Cancer Therapeutics (Biotherapeutics) Market
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49938
Introduction
The global Cancer Therapeutics (Biotherapeutic) Market is undergoing rapid expansion as biologics, targeted therapies, and immunotherapies redefine cancer treatment standards. With rising cancer prevalence, precision medicine advancements, and a surge in next-generation treatment innovations, the oncology biotherapeutics segment is at the forefront of life sciences growth. This press release presents the major trends, breakthroughs, and long-term market outlook through 2034.
Key Takeaways
• Market Size 2024: USD 158.6 Billion
• Forecast for 2034: USD 262.4 Billion
• CAGR (2025-2034): 5.1%
• Top Therapeutic Classes: Monoclonal antibodies, CAR-T cell therapies, checkpoint inhibitors
• Fastest-growing Technologies: Cell & gene therapy-based cancer treatments
• Leading Regions: North America and Asia-Pacific
Market Story
Cancer biotherapeutics have transformed oncology care, offering targeted, effective treatments with fewer systemic side effects compared to conventional chemotherapy. Over the last decade, immunotherapies-including PD-1/PD-L1 inhibitors, CAR-T cell therapies, and bispecific antibodies-have drastically improved survival outcomes for several hard-to-treat cancers.
Pharmaceutical companies continue to expand their biologics pipelines in areas such as:
• Checkpoint inhibitors for advanced solid tumors
• CAR-T cell therapy for hematological malignancies
• Targeted monoclonal antibodies
• Oncolytic viral therapies
• Cancer vaccines & neoantigen therapies
• Antibody-drug conjugates (ADCs)
The combination of precision diagnostics, genetic profiling, AI-driven drug discovery, and biomarker-guided therapies is making oncology more personalized and effective.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/49938/cancer-therapeutics-biotherapeutic-market
Market Segments
By Therapeutic Type
• Monoclonal Antibodies (mAbs) - Largest Market Share
• Immunotherapy (Checkpoint inhibitors, CAR-T, T-cell therapies)
• Targeted Therapy Biologics
• Antibody-Drug Conjugates (ADCs) - Fastest-growing biologics segment
• Cancer Vaccines
• Oncolytic Virus Therapies
• Cytokine & Interleukin-based Therapies
By Cancer Type
• Lung Cancer (Largest demand for targeted therapy)
• Breast Cancer
• Colorectal Cancer
• Leukemia & Lymphoma (High adoption of CAR-T)
• Prostate Cancer
• Melanoma (Checkpoint inhibitor-driven growth)
• Ovarian & Cervical Cancer
• Other Solid Tumors & Rare Cancers
By Route of Administration
• Injectable (Dominant)
• Oral Targeted Biologics
• Intratumoral / Localized Delivery (Emerging)
By End User
• Hospitals & Oncology Centers
• Specialty Cancer Clinics
• Biotechnology & Pharmaceutical Companies
• Research Institutes & Clinical Trial Facilities
By Region
• North America: Leading innovation hub with strong biologics adoption
• Europe: Major center for clinical trials & precision oncology
• Asia-Pacific: Fastest-growing region with expanding cancer burden
• South America & Middle East/Africa: Improving oncology infrastructure
Recent Developments
• 2024: Multiple CAR-T therapies approved for new leukemia and lymphoma indications.
• 2025: Advancements in bispecific antibodies accelerate treatment options for solid tumors.
• 2023-2025: AI-driven biomarker discovery platforms shorten biologics development timelines.
• 2024: Surge in antibody-drug conjugate (ADC) approvals with superior tumor-targeting capabilities.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49938
Expert Quote
"Cancer biotherapeutics are driving a new era in oncology, with targeted biologics and immunotherapies delivering unprecedented clinical outcomes. As innovation accelerates, the next decade will redefine how cancer is treated worldwide,"
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Key Market Drivers
• Rising global cancer incidence
• Increased adoption of immunotherapy & precision oncology
• Strong investments in biologics and advanced R&D pipelines
• Growing approvals for targeted and personalized treatments
• Expansion of clinical trials for rare and drug-resistant cancers
• Technological breakthroughs in genomics and molecular biology
Forecast & Future Outlook
The Cancer Therapeutics (Biotherapeutics) Market will surpass USD 262 billion by 2034, driven by:
• Expansion of CAR-T and next-generation cell therapies
• Increased approvals of personalized cancer vaccines
• Growing focus on AI-driven oncology drug development
• Higher adoption of ADCs for hard-to-treat solid tumors
• Strengthening global oncology infrastructure in emerging markets
The future of cancer care is moving toward personalized, immune-driven, gene-modulated, and minimally invasive biotherapeutic solutions.
Conclusion
The Cancer Therapeutics (Biotherapeutics) Market is positioned for transformative growth as next-generation biologics reshape oncology treatment paradigms. Continued innovation, deeper scientific understanding, and broader global access will propel the sector to new heights over the next decade.
This report is also available in the following languages : Japanese (がん治療薬バイオ医薬品市場), Korean (암 치료제 생물 치료제 시장), Chinese (癌症治疗生物治疗市场), French (Marché des biothérapies anticancéreuses), German (Markt für biotherapeutische Krebsbehandlungen), and Italian (Mercato bioterapeutico della terapia del cancro), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49938
Our More Reports:
Pheochromocytoma Market
https://exactitudeconsultancy.com/reports/71562/pheochromocytoma-market
Pharmacy Management System Market
https://exactitudeconsultancy.com/reports/49869/pharmacy-management-system-market
Pain Patch Market
https://exactitudeconsultancy.com/reports/49872/pain-patch-market
Antibiotic Resistance Market
https://exactitudeconsultancy.com/reports/49874/antibiotic-resistance-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Therapeutics (Biotherapeutics) Market to Reach USD 262.4 Billion by 2034 here
News-ID: 4268765 • Views: …
More Releases from Exactitude Consultancy
Gabapentin Market is expected to reach over USD 3.0 billion by 2034
In 2024, the global Gabapentin market is estimated at approximately USD 1.8 billion, and it is projected to reach about USD 3.0 billion by 2034, corresponding to a compound annual growth rate (CAGR) of around 6.3% during the forecast period. The market is driven by increasing incidence of neurological conditions (seizures, neuropathic pain) and growing off-label use, while the largest share is held by the North American region.
Download Full PDF…
Flexible Endoscopes Market is anticipated to reach over USD 5.7 billion by 2034
The global Flexible Endoscopes Market was valued at approximately USD 3.5 billion in 2024 and is projected to reach around USD 5.7 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 4.9% across the forecast period. North America leads the market, contributing roughly 40% of revenue, while the Asia-Pacific region is expected to grow fastest, with a projected CAGR of about 7.2%. The gastrointestinal endoscope segment holds…
Brain Tumor Therapeutics Market to Reach USD 6.84 Billion by 2034
Growing burden of malignant brain tumors, technological breakthroughs in targeted therapies, and expanding clinical trials in immuno-oncology accelerate global market growth.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49936
Introduction
The global Brain Tumor Therapeutics Market is undergoing significant transformation as advancements in immunotherapy, targeted drugs, and precision oncology reshape treatment outcomes for patients with malignant and non-malignant brain tumors. Rising incidence of glioblastoma multiforme (GBM), improved diagnostic imaging capabilities, and…
Medical Tape Market is anticipated to reach over USD 15.43 billion by 2029
The medical tape market is estimated at approximately USD 9.42 billion in 2022 and is projected to reach around USD 15.43 billion by 2029, corresponding to a compound annual growth rate (CAGR) of about 5.64% from 2023 to 2029.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/50174
Market Segmentation Highlights
• By Product/Backing Material: Paper tapes, plastic (film) tapes, fabric tapes.
• By Application: Wound care, surgical procedures, device fixation and monitoring, trauma/orthopedic settings.
• By…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
